Recombinant Glypican 3 antibody
Quick Overview for Recombinant Glypican 3 antibody (ABIN4949349)
Target
See all Glypican 3 (GPC3) AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purification
- Protein A affinity chromatography
-
Immunogen
- A partial human protein was used as the immunogen for the recombinant Glypican-3 antibody.
-
Isotype
- IgG kappa
-
-
-
-
Application Notes
-
Optimal dilution of the recombinant Glypican-3 antibody should be determined by the researcher.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.\. FACS: 0.5-1 μg/10e6 cells in 0.1ml,Immunofluorescence: 0.5-1 μg/mL,Immunohistochemistry (FFPE): 0.5-1 μg/mL for 30 min at RT,Prediluted IHC only format: incubate for 30 min at RT (1)
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Preservative
- Azide free
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store the recombinant Glypican-3 antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
-
-
- Glypican 3 (GPC3)
-
Alternative Name
- Glypican 3 / GPC3
-
Background
- Glypican-3 is a proteoglycan that bears heparan sulfate. Inhibits the dipeptidyl peptidase activity of DPP4. May be involved in the suppression/modulation of growth in the predominantly mesodermal tissues and organs. May play a role in the modulation of IGF2 interactions with its receptor and thereby modulate its function. May regulate growth and tumor predisposition. [UniProt]
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-